Biosceptre
Pre-clinicalA Promise Beyond Cancer Envisioning the future of targeted therapeutics Biosceptre is driving innovation to bring new and progressive therapies to a wide range of cancer patients. Our focus is a multiple-targeted universal CAR T system with the potential to improve the lives of millions of patients across the world who are suffering from
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $1.3M
About
A Promise Beyond Cancer Envisioning the future of targeted therapeutics Biosceptre is driving innovation to bring new and progressive therapies to a wide range of cancer patients. Our focus is a multiple-targeted universal CAR T system with the potential to improve the lives of millions of patients across the world who are suffering from
DiagnosticsSmall Molecules
Funding History
2Total raised:$1.3M
Grant$800KJun 15, 2017
Grant$500KJun 15, 2015